(Q36609957)

15 August 2017

title

Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration (English)

1 reference

15 August 2017

1 reference

Raymond Tak Fai Cheung

1

1 reference

15 August 2017

George L Tipoe

2

1 reference

15 August 2017

Sidney Tam

3

1 reference

15 August 2017

Edmond Shiu Kwan Ma

4

1 reference

15 August 2017

Liang Yu Zou

5

1 reference

15 August 2017

Pui Shan Chan

6

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Journal of Pineal Research

15 August 2017

published in

1 reference

15 August 2017

volume

41

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

337-343

1 reference

Tissue plasminogen activator for acute ischemic stroke

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

NXY-059 for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin mitigates mitochondrial malfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Current status and perspectives of neuroprotection in ischemic stroke treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

New toxicity data for the propylene glycol ethers - a commitment to public health and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin reduces nitric oxide level during ischemia but not blood-brain barrier breakdown during reperfusion in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

Existence of melatonin in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00372.X

10.1111/J.1600-079X.2006.00372.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference